Back to Search
Start Over
69 Ruxolitinib, a Selective JAK1/2 Inhibitor, Blocks IL-13/STAT6 Signaling and Eotaxin-3 Expression in Esophageal Epithelial Cells and Fibroblasts: A Potential Agent to Treat Inflammation and Fibrosis in EoE.
- Source :
- Gastroenterology (00165085); Apr2016 Supplement 1, Vol. 150, pS18-S18, 1p
- Publication Year :
- 2016
Details
- Language :
- English
- ISSN :
- 00165085
- Volume :
- 150
- Database :
- Supplemental Index
- Journal :
- Gastroenterology (00165085)
- Publication Type :
- Academic Journal
- Accession number :
- 114620690
- Full Text :
- https://doi.org/10.1016/S0016-5085(16)30186-X